![Stephen Dilly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Dilly
Président chez
CODEXIS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Stephen George Dilly is President, Chief Executive Officer & Director at Sonoma Biotherapeutics, Inc. since 2025.
He is Chairman at Codexis, Inc. since 2020.
He serves as Director at Adjuvance Technologies, Inc. and Director at Aurimi Therapeutics, Inc. since 2020.
Former roles include President, Chief Executive Officer & Director at Sierra Oncology, Inc. from 2020 to 2022; President, Chief Executive Officer & Director at Aimmune Therapeutics, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at PhotoThera, Inc. from 2011 to 2012; President, Chief Executive Officer & Director at APT Pharmaceuticals, Inc. from 2006 to 2011; Chief Medical Officer & SVP-Development at CHIRON Biopharmaceuticals from 2003 to 2006; Vice President-Development Sciences at Genentech, Inc. from 2002 to 2003; Independent Director at Sangamo Therapeutics, Inc. from 2010 to 2020; Director at Avigen, Inc. from 2007 to 2009; Executive Chairman at DNAtrix, Inc.; Chairman at Cognoa, Inc.; and Advisor at Physic Ventures LLC.
Education includes two doctorates from the University of London, conferred in 1982 and 1988.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CODEXIS, INC. 0,8% | 20/04/2026 | 727 053 ( 0,8% ) | 2 M $ | 31/05/2026 |
Postes actifs de Stephen Dilly
| Sociétés | Poste | Début |
|---|---|---|
| CODEXIS, INC. | Président | - |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Directeur/Membre du Conseil | 07/02/2020 |
Adjuvance Technologies, Inc.
 Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Directeur/Membre du Conseil | - |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Directeur Général | 17/11/2025 |
Anciens postes connus de Stephen Dilly
| Sociétés | Poste | Fin |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Directeur Général | 01/07/2022 |
| SANGAMO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/09/2020 |
| AIMMUNE THERAPEUTICS, INC. | Directeur Général | 19/06/2018 |
PhotoThera, Inc.
 PhotoThera, Inc. Medical SpecialtiesHealth Technology Develops and distributes infrared therapeutic devices | Directeur Général | 01/12/2012 |
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Directeur Général | 01/12/2011 |
Formation de Stephen Dilly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Develops gene therapy products | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
PhotoThera, Inc.
PhotoThera, Inc. Medical SpecialtiesHealth Technology Develops and distributes infrared therapeutic devices | Health Technology |
APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Health Technology |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Physic Ventures LLC
 Physic Ventures LLC Investment ManagersFinance Physic Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Finance |
CHIRON Biopharmaceuticals | |
Adjuvance Technologies, Inc.
Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Offers a mobile app and proprietary algorithm to enable early detection of autism | Health Services |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
